Venture Capital

An Israeli deep-tech firm has launched from stealth with a novel AI platform to solve the energy bottleneck strangling the global AI revolution.

Cingulate Inc. faces a critical FDA decision for its novel ADHD drug, but manufacturing queries and a tight cash runway create a high-stakes countdown.

Swiss firm H55's flight-proven batteries are fast-tracking a new hybrid-electric regional aircraft demonstrator, promising a 30% leap in fuel efficiency.

Semiconductor firm Guerrilla RF is leveraging off-the-shelf parts to accelerate next-gen satellite tech, from military comms to direct-to-cell service.

With veteran leader Brian McKelligon at the helm, Infinity Bio aims to commercialize its powerful MIPSA platform and redefine precision medicine.

China is rolling out a 10-day visa-free transit policy and promoting immersive cultural tours. But can it overcome geopolitical headwinds to revive tourism?

The controversial safety app Citizen is in 15 new cities. It promises real-time alerts but brings a history of privacy concerns and vigilantism fears.

With a massive $68.7M seed round and novel T-cell engager tech, Shanghai's Excalipoint is pioneering a new model for rapid drug development.

Operator of China's BOSS Zhipin announces a major dividend and buyback plan, signaling deep confidence in its market dominance and future profitability.

With a new context-aware AI and $45M from General Catalyst, the PowerPoint rival aims to automate design and conquer the global presentation market.

With a new CEO and Chair, IsomAb is advancing a disease-modifying drug for 9 million angina patients, eyeing a major Series A fundraise.

The strategic divestment to Blue Moon Metals highlights Liberty Gold's pivot to its core gold assets and a broader mining trend of portfolio specialization.

A new collaboration will use innovative protein binders to fight animal disease, bolstering global food security and public health under the One Health framework.

Student innovators unveil an AI lifeline for ICUs at Quest Global's Ingenium, tackling a critical medical crisis and showcasing India's engineering future.

Shenzhen's CIBF 2026 will unveil next-gen sodium-ion and solid-state batteries, highlighting China's soaring exports amid rising global competition.

A novel drug mimicking exercise aims to solve a major problem with today's weight-loss meds: muscle loss. Atrogi's ATR-258 has entered a key human trial.

The social media giant posts a 70% overseas revenue jump, but a sharp decline in paying users for its core apps Momo and Tantan paints a complex picture.

A key investment in a massive French synthetic fuel plant aims to tackle aviation emissions, driven by EU mandates and advanced carbon capture technology.

A new university-industry partnership aims to solve the key challenges of orbital computing, validating early bets on the future of decentralized AI.

From Hong Kong to the world, Winson Siu's rigorous online teaching method is transforming student outcomes and building a multi-million dollar business.